SCHEMBL7781671

SCHEMBL7781671

CCCCCCCc1ccc(-c2ccc(B(O)O)c(F)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 9/20 0.64
RARA P10276 2/20 0.64
RARG P13631 1/20 0.64
LPL P06858 5/20 0.55
LIPG Q9Y5X9 5/20 0.55
TRPV1 Q8NER1 1/20 0.55
MGLL Q99685 1/20 0.55
ALDH1A1 P00352 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
MTOR P42345 1/20 0.50
KMT2A Q03164 1/20 0.50
HSD17B10 Q99714 2/20 0.48
TSHR P16473 1/20 0.48
ESR1 P03372 2/20 0.47
ADRA2A P08913 2/20 0.47
ADORA3 P0DMS8 2/20 0.47
TACR2 P21452 2/20 0.47
SLC6A2 P23975 2/20 0.47
SLC6A4 P31645 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29957265 1.00 RARB (0.64) RARBRARARARGLPLLIPG
SCHEMBL1533765 0.98 RARB (0.62) RARBRARARARGLPLLIPG
SCHEMBL29955233 0.98 RARB (0.62) RARBRARARARGLPLLIPG
SCHEMBL29956137 0.94 RARB (0.56) RARBRARARARGLPLLIPG
SCHEMBL1533780 0.88 LPL (0.50) RARBRARARARGLPLLIPG
SCHEMBL31028375 0.88 LPL (0.50) RARBRARARARGLPLLIPG
SCHEMBL29952644 0.86 LIPG (0.56) RARBRARARARGLPLLIPG
SCHEMBL6555943 0.86 LIPG (0.56) RARBRARARARGLPLLIPG
SCHEMBL19384703 0.85 RARB (0.60) RARBRARARARGLPLLIPG
SCHEMBL23631142 0.84 LIPG (0.57) RARBRARARARGLPLLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2023-05-02 US disclosed
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2023-05-02 US disclosed
US-20210214299-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2021-07-15 US disclosed
EP-1144546-A3 FLUORINATED TERPHENYLS QinetiQ Limited (GB) 2002-08-28 EP disclosed
EP-1144546-A2 FLUORINATED TERPHENYLS QinetiQ Limited (GB) 2001-10-17 EP disclosed
WO-2000004111-A2 FLUORINATED TERPHENYLS THE SECRETARY OF STATE FOR DEFENCE (GB) 2000-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214299-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME SKP1, PKN1, KTN1 RARB 3863/4885RARA 4220/4885RARG 4550/4885
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same SKP1, PKN1, KTN1 RARB 3863/4885RARA 4220/4885RARG 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.